OMNITROPE

This brand name is authorized in United States. It is also authorized in Albania, Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug OMNITROPE contains one active pharmaceutical ingredient (API):

1	Somatropin UNII NQX9KB6PCL - SOMATROPIN
	Somatropin is a potent metabolic hormone of importance for the metabolism of lipids, carbohydrates and proteins. In children with inadequate endogenous growth hormone, somatropin stimulates linear growth and increases growth rate. In adults, as well as in children, somatropin maintains a normal body composition by increasing nitrogen retention and stimulation of skeletal muscle growth, and by mobilization of body fat.
	Read more about Somatropin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01AC01	Somatropin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AC Somatropin and somatropin agonists
Discover more medicines within H01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	123/237, 770/237
AU	Pharmaceutical Benefits Scheme	10446T, 10485W, 10490D, 10506Y, 10507B, 10512G, 10514J, 10518N, 10519P
BR	Câmara de Regulação do Mercado de Medicamentos	511515080060403, 511518001153415, 511518002151416
CA	Health Products and Food Branch	02325063, 02325071, 02459647
EE	Ravimiamet	1238677, 1238688, 1238699, 1368996, 1369009, 1369021, 1369032, 1369043, 1369054, 1662870, 1662881, 1662892
ES	Centro de información online de medicamentos de la AEMPS	106332010, 106332013, 106332014, 106332016, 106332017
FI	Lääkealan turvallisuus- ja kehittämiskeskus	066689, 483821, 515191, 540046, 567077
FR	Base de données publique des médicaments	63450352, 64316662, 65086919
GB	Medicines & Healthcare Products Regulatory Agency	127952, 232666, 232668, 296804
IT	Agenzia del Farmaco	037106010, 037106022, 037106034, 037106046, 037106059, 037106061, 037106073, 037106085, 037106097, 037106109, 037106111, 037106123, 037106135, 037106147, 037106150, 037106162, 037106174, 037106186
LT	Valstybinė vaistų kontrolės tarnyba	1030288, 1030289, 1030290, 1030291, 1030292, 1030293, 1030297, 1030298, 1030299, 1061349, 1061350, 1061351, 1073840, 1073841, 1073842, 1073843, 1073844, 1073845
NL	Z-Index G-Standaard, PRK	53082, 53090, 53104, 80705
NZ	Medicines and Medical Devices Safety Authority	15952, 15953, 15954
PL	Rejestru Produktów Leczniczych	100160901, 100160999, 100176954, 100180157, 100252081, 100302181, 100302198
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W51608001, W52337001, W52337002, W52345001, W52345002, W52345003, W52346001, W52346002, W52346003, W59825001, W59825002, W59825003, W63193001, W63194001
TN	Direction de la Pharmacie et du Médicament	11073021H
TR	İlaç ve Tıbbi Cihaz Kurumu	8681428950126, 8681428950133, 8681428950140, 8699516953805, 8699516953812, 8699516953829, 8699516953836, 8699516953843, 8699516953850
US	FDA, National Drug Code	0781-3001, 0781-3004